Showing 1121-1130 of 8663 results for "".
Limited Liability Companies and Family Limited Partnerships, Part 1
https://practicaldermatology.com/topics/practice-management/limited-liability-companies-and-family-limited-partnerships-part-1/23513/A look at these legal structures that are the foundation of asset protection for most physicians.The ACTS Program: Adding Testing to Your Defense Against COVID-19
https://practicaldermatology.com/issues/supplements/the-acts-program-adding-testing-to-your-defense-against-covid-19/23419/Adopting a simple testing and safety platform for personal protective equipment and sterilization protocols adds a layer of protection for patients and office staff.Currents: Diversity In Dermatology
https://practicaldermatology.com/topics/skin-of-color/currents-diversity-in-dermatology/23760/Graduating from Dermatology Residency into the COVID-19 Job Market
https://practicaldermatology.com/youngmd-connect/resident-resource-center/graduating-from-dermatology-residency-into-the-covid-19-job-market/23437/Third-year dermatology residents are graduating into an uncertain job market. What does the future hold?SDRIFE Induced by Liposomal Daunorubicin and Cytarabine
https://practicaldermatology.com/youngmd-connect/resident-resource-center/sdrife-induced-by-liposomal-daunorubicin-and-cytarabine/20830/Acne and Rosacea Awareness: Clinician Perspectives
https://practicaldermatology.com/topics/acne-rosacea/acne-and-rosacea-awareness-clinician-perspectives/23927/Key ways to improve treatment outcomes for patients with rosacea and acne.Currents: Cosmetic Dermatology: Where are we now?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/currents-cosmetic-dermatology-where-are-we-now/23644/Case Report: DRESS; NYU School of Medicine's Free Degree Initiative; Call for Cases
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-dress-nyu-school-of-medicines-free-degree-initiative-call-for-cases/20330/Currents: Reboot Your Practice
https://practicaldermatology.com/topics/practice-management/currents-reboot-your-practice/20638/High-Dose Ipilimumab Shows Benefits in Advanced Melanoma: Implications for Care
https://practicaldermatology.com/topics/skin-cancer-photoprotection/high-dose-ipilimumab-shows-benefits-in-advanced-melanoma-implications-for-care/20687/Although treatment is associated with a high rate of toxicity, survival benefit is extended at a higher dose.